Cheav Sotheara sold $109K of ACMR
Cheav Sotheara (See remarks) sold 1,300 shares of ACM Research, Inc. (ACMR) at $84.08 ($0.11M total) on 2026-06-04 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
Because the sale is pre-arranged, it usually carries less signaling weight than discretionary selling; the main tradable element is short-term sentiment around insider activity.
Market read
A single disclosed 10b5-1 sale is unlikely to reset valuation expectations without additional company-specific news.
What to watch
The article provides only the sale details; it does not quantify total insider net activity over time or whether other insiders/funds were buying.
Background
The article is an SEC Form 4 insider transaction: an officer reported an open-market sale of ACM Research shares under a Rule 10b5-1 plan.
Ticker impact
ACM Research officer Cheav Sotheara sold 1,300 shares in an open-market transaction, disclosed via SEC Form 4.
Low likelihood of a sustained price move; at most, minor negative drift around insider-selling headlines.
The filing is an officer sale under a pre-arranged Rule 10b5-1 plan, with no accompanying operational or financial catalyst stated.
Market effects
No direct sector read-through; this is company-specific insider transaction disclosure.
None indicated.
None indicated.
Counterpoint
Even with 10b5-1, repeated insider selling can coincide with periods of reduced confidence; traders may still fade strength if selling frequency increases.
Key entities
- issuerACM Research, Inc.
Subject of the SEC Form 4 insider transaction disclosure.
- insiderCheav Sotheara
Officer who sold 1,300 shares of ACM Research on 2026-06-04.
